CompletedNCT01605253
Eszopiclone for the Treatment of PTSD
Medication studyAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Chicago, United StatesSee all locations and recruitment
- Activities
- Medication described in the protocol · Placebo comparator
- Compensation
- Payment and expense reimbursement have not been verified.
Study information
Study start dateMarch 2012
- Recruitment status
- Completed
- Enrollment listed in the registry
- 81
- Sponsor
- Rush University Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01605253
- Official title
Show the full official title
Eszopiclone for the Treatment of PTSD
Recruitment & locations
CompletedChicago
Questions about this study
Who is behind this study?
The study sponsor is Rush University Medical Center, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Eszopiclone and Placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me